Most Profitable Pharmaceuticals Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
144.07 B
(0.07)
 1.04 
(0.08)
2NVO Novo Nordisk AS
83.68 B
(0.13)
 3.26 
(0.43)
3RDY Dr Reddys Laboratories
55.68 B
(0.09)
 1.63 
(0.15)
4JNJ Johnson Johnson
13.33 B
(0.07)
 1.14 
(0.08)
5NVS Novartis AG ADR
8.57 B
(0.09)
 1.09 
(0.10)
6BMY Bristol Myers Squibb
8.04 B
 0.09 
 1.96 
 0.17 
7AZN AstraZeneca PLC ADR
6.9 B
(0.01)
 1.58 
(0.02)
8SNY Sanofi ADR
5.4 B
(0.02)
 1.55 
(0.02)
9LLY Eli Lilly and
5.24 B
 0.00 
 2.14 
(0.01)
10GSK GlaxoSmithKline PLC ADR
4.93 B
(0.04)
 1.45 
(0.06)
11ZTS Zoetis Inc
2.34 B
(0.07)
 1.32 
(0.10)
12PFE Pfizer Inc
2.17 B
(0.01)
 1.55 
(0.02)
13RPRX Royalty Pharma Plc
1.13 B
 0.16 
 2.00 
 0.31 
14OGN Organon Co
1.02 B
(0.08)
 2.19 
(0.17)
15JAZZ Jazz Pharmaceuticals PLC
414.83 M
 0.12 
 1.76 
 0.22 
16MRK Merck Company
365 M
(0.03)
 1.28 
(0.04)
17PBH Prestige Brand Holdings
209.34 M
 0.09 
 1.34 
 0.11 
18INVA Innoviva
179.72 M
(0.03)
 1.09 
(0.04)
19AMPH Amphastar P
137.54 M
(0.19)
 2.71 
(0.52)
20HRMY Harmony Biosciences Holdings
128.85 M
 0.14 
 2.16 
 0.29 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.